Skip to content
naulon

Not checkedNot checked for notices yet.

A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice

Rong Zhang, Dedong Li, Kun Xu and 4 more

The Lancet Microbe · 2022

doi:10.1016/s2666-5247(21)00331-1 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

SARS-CoV-2 vaccination provides good protection against severe illness and death from COVID-19; however, the waning of immunity against SARS-CoV-2 in fully vaccinated individuals has been reported mostly 6 months after the last vaccine dose.1–3 A booster vaccination (third dose of vaccine) has been proposed and initiated in many countries; and a prime-boost sequential immunisation approach is thought to be beneficial.4

Abstract licence: CC BY-NC

References5

    5 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.